Post Profile






States Allege British Drug Company Tried to Keep Generic Suboxone Off the Market

Attorneys general from 35 states and the District of Columbia are suing a British drug company, alleging it tried to keep less expensive generic versions of the opioid addiction treatment Suboxone off the market. The post States Allege British Drug Company Tried to Keep Generic Suboxone Off the Market appeared first on Partnership for Drug-Free Kids.
read more

share

Related Posts


Pfizer Hit With $43 Million Settlement For Misleading Marketing Of Drugs

Lifestyle / Shopping : The Consumerist

The attorneys general of 33 states and the District of Columbia have reached a $43 million settlement with pharma giant Pfizer over allegations that the company ignored FDA warnings and made misleading marketing claims about its dru...

Attorney General Martha Coakley And 32 Other Attorneys General Announce Record $62 Milion Settlement With Drug Company

Health : Medical News Today

Attorney General Martha Coakley's office, along with 32 other attorneys general, reached a record $62 million settlement with Eli Lilly and Company (Eli Lilly) resolving allegations of improper marketing of the atypical antipsychoti...

First Large-Scale Study On Treatment Of Prescription Opioid Addiction Finds Suboxone Most Effective

Health : Medical News Today

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in the online e...

Results From First Large Scale Study On Treatment Of Prescription Opioid Addiction

Health : Medical News Today

People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in Archives of General Psychiatry and c...

U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

Health : Reuters: Health

WASHINGTON (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market.

Comments


Drug Addiction
Copyright © 2016 Regator, LLC